| Sep 26 |
Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
|
| Sep 20 |
VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis
|
| Sep 20 |
Novo sinks on obesity drug results; Sanofi reveals anticipated MS data
|
| Sep 20 |
FDA declines approval of Vanda’s gastroparesis treatment
|
| Sep 19 |
Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today
|
| Sep 19 |
Vanda slips as FDA rejects therapy for stomach condition
|
| Sep 19 |
FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis
|
| Sep 11 |
Vanda Pharmaceuticals Announces Participation in the 2024 Cantor Global Healthcare Conference
|
| Sep 5 |
Vanda's Struggles Persist Despite New Drug Launches And Takeover Bids
|
| Sep 4 |
Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference
|
